| T3 clinical protocols | |
| Triage | |
| • All patients presenting with signs and symptoms of suspected stroke should be triaged to Australasia Triage Scale (ATS) categories 1 or 2 (seen within 10 min) | |
| Treatment | |
| Thrombolysis (tissue-type plasminogen activator) | |
| • All patients to be assessed for thrombolysis eligibility | |
| • All eligible patients to receive thrombolysis | |
| Fever | |
| • All patients to have their temperature taken on admission to emergency department (ED) and then at least four hourly whilst they remain in ED | |
| • Treat temperature 37.5 °C or greater with paracetamol within 1 h | |
| Sugar | |
| • Formal venous (laboratory) blood glucose level (BGL) on admission to ED | |
| • Record finger prick BGL on ED admission and monitor finger prick BGL every 6 h (or greater if elevated) | |
| • Administer insulin to all patients with BGL > 10 mmol/L (180 mg/dL) within 1 h | |
| Swallow | |
| • Patients remain Nil By Mouth until a swallow screen by non-speech pathologist (SP) or swallow assessment by SP performed, i.e.: | |
| ◦ No oral food or fluids to be given prior to swallow screen by non-SP or swallow assessment by SP | |
| ◦ No oral medications administered prior to swallow screen by non-SP or swallow assessment by SP | |
| • All patients who fail the screen are to be assessed by a SP | |
| Transfer | |
| • All patients with stroke to be discharged from ED within 4 h | |
| • All patients with stroke to be admitted to the hospital’s stroke unit | |
| T3 Implementation strategy | |
| Multidisciplinary Workshopsa | |
| Workshop 1 - Barriers and Enablers Assessment (one at each site, 60 min) | |
| • To present the details of the trial | |
| • To identify the local barriers and enablers | |
| • To identify the local site clinical champion | |
| Workshop 2 - Action Plan (one at each site, 60 min) | |
| • To discuss the action plan to address the barriers | |
| • To ascertain the actions already taken to address the barriers | |
| • To identify the new local barriers | |
| Didactic and interactive educationa (minimum one at each site, 30 min) | |
| • A 20-min PowerPoint presentation and a 10-min discussion | |
| • An 8-min video developed by an academic ED nurse clinician/opinion leader | |
| Use of clinical opinion leaders | |
| • Key national clinical opinion leaders at Workshop 1 and available as needed for any site-requested queries | |
| • Clinical champions from ED and stroke unit | |
| • Reminders | |
| • Reminder poster to display in ED- and pocket-sized card to attach to ID lanyard for staff | |
| • Proactive direct contact every 6 weeks in the form of the following: | |
| ◦ Site visits every 3 months (face-to-face) using an action plan | |
| ◦ Teleconferences every 3 months with clinical champions and site coordinator using an action plan | |
| • Emails—reactive and monthly proactive emails | |
| • Telephone support—reactive | |
| • Telephone support—reactive and as needed |